Page 60 - Functional impairment and cues for rehabilitation of head and neck cancer patients -

58
Chapter 2
29. Rodin D, Caulley L, Burger E, et al. Cost-Effectiveness Analysis of Radiation Therapy Versus Transoral Robotic Surgery for Oropharyngeal Squamous Cell Carcinoma. Int J Radiat Oncol Biol Phys. 2017;97(4):709-17.
30. Ang KK, Trotti A, Brown BW, et al. Randomized trial addressing risk features and time factors of surgery plus radiotherapy in advanced head-and- neck cancer. Int J Radiat Oncol Biol Phys. 2001;51(3):571-8.
31. Owadally W, Hurt C, Timmins H, et al. PATHOS: a phase II/III trial of risk-stratified, reduced intensity adjuvant treatment in patients undergoing transoral surgery for Human papillomavirus (HPV) positive oropharyngeal cancer. BMC Cancer. 2015;15:602.
32. Amit M, Hutcheson K, Zaveri J, et al. Patient-reported outcomes of symptom burden in patients receiving surgical or nonsurgical treatment for low-intermediate risk oropharyngeal squamous cell carcinoma: A comparative analysis of a prospective registry. Oral oncology. 2019;91:13-20.
33. O’Hara J, Goff D, Cocks H, Moor J. One-year swallowing outcomes following transoral laser microsurgery +/- adjuvant therapy versus primary chemoradiotherapy for advanced stage oropharyngeal squamous cell carcinoma. 2016;41(2):169-75.
34. More YI, Tsue TT, Girod DA, et al. Functional swallowing outcomes following transoral robotic surgery vs primary chemoradiotherapy in patients with advanced-stage oropharynx and supraglottis cancers. JAMA otolaryngology-- head & neck surgery. 2013;139(1):43-8.
35. Sinclair CF, McColloch NL, Carroll WR, et al. Patient-perceived and objective functional outcomes following transoral robotic surgery for early oropharyngeal carcinoma. Arch Otolaryngol Head Neck Surg. 2011;137(11):1112-6.
36. Pedro C, Mira B, Silva P, et al. Surgery vs. primary radiotherapy in early-stage oropharyngeal cancer. Clin Transl Radiat Oncol. 2018;9:18-22.
37. Sher DJ, Agiro A, Zhou S, Day AT, DeVries A. Commercial Claims-Based Comparison of Survival and Toxic Effects of Definitive Radiotherapy vs
Primary Surgery in Patients With Oropharyngeal Squamous Cell Carcinoma. JAMA Otolaryngol Head Neck Surg. 2018;144(10):913-22.
38. Lamarre ED, Seth R, Lorenz RR, et al. Intended single-modality management of T1 and T2 tonsillar carcinomas: retrospective comparison of radical
tonsillectomy vs radiation from a single institution. Am J Otolaryngol. 2012;33(1):98-103.
39. Kelly JR, Park HS, An Y, et al. Comparison of Survival Outcomes Among Human Papillomavirus-Negative cT1-2 N1-2b Patients With Oropharyngeal
Squamous Cell Cancer Treated With Upfront Surgery vs Definitive Chemoradiation Therapy: An Observational Study. JAMA Oncol. 2017;3(8):1107-
11.
40. Ang KK, Harris J, Wheeler R, et al. Human papillomavirus and survival of patients with oropharyngeal cancer. N Engl J Med. 2010;363(1):24-35.